台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    86.0
  • 漲跌
    ▲2.3
  • 漲幅
    +2.75%
  • 成交量
    416
  • 產業
    上櫃 生技醫療類股▲0.81%
  • 117人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
訊聯 (1784)籌碼相關-永豐金-板盛 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/1403/2204/0404/2005/0405/1805/3006/0806/2207/0407/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1212/2012/3001/0801/1602/0402/1202/2077.58082.58587.59092.5Mar '24May '24Jul '24Sep '24Nov '24Jan '2560d90dAll

永豐金-板盛 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/0600.00186.0085.80-1437-0.23%
2025/02/0500.00385.1084.60-3437-0.69%
2025/01/22081.90282.5583.10-2437-0.46%
2025/01/17181.0000.0081.0014460.22%
2025/01/13180.6000.0079.6014570.22%
2025/01/1000.000.181.8582.60-0.1451-0.02%
2025/01/07183.00182.0082.0004670.00%
2025/01/06081.5000.0081.5004750.01%
2025/01/0200.00180.5080.50-1479-0.21%
2024/12/3100.00379.5079.50-3481-0.62%
2024/12/27081.7000.0080.1004950.01%
2024/12/2600.002881.8480.90-28525-5.33%
2024/12/2500.00180.7080.30-1521-0.19%
2024/12/2400.00181.6080.00-1527-0.19%
2024/12/1900.003380.0479.50-33547-6.02%
2024/12/18182.90182.1082.4005480.00%
2024/12/16284.4500.0082.0025980.33%
2024/12/13187.70490.5087.20-3587-0.51%
2024/12/12294.55392.7092.60-1580-0.17%
2024/12/112997.90298.5097.60275684.75%
2024/12/101093.5800.0093.80105591.79%
2024/12/09292.45193.7092.3015610.18%
2024/12/06495.2800.0095.0045600.71%
2024/12/05499.7500.0099.6045520.72%
2024/12/0413101.424101.38100.5095501.64%
2024/12/0300.00197.8095.70-1521-0.19%
2024/12/02896.55297.5596.5065231.15%
2024/11/29696.6800.0097.0065191.16%
2024/11/212294.251795.6893.3055840.86%
2024/11/20197.00296.2095.90-1565-0.18%
2024/11/1500.00187.1086.90-1629-0.16%
2024/11/13090.0000.0089.5006430.00%
2024/11/12189.1000.0089.1016530.15%
2024/10/29192.50193.7092.5008640.00%
2024/10/24398.47199.5096.2029830.20%
2024/10/2300.00299.2599.80-21,012-0.20%
2024/10/22197.3000.0097.4011,0670.09%
2024/10/17194.00194.7094.2001,5350.00%
2024/10/16295.10296.8594.5001,5540.00%
2024/10/11293.4000.0090.9021,5710.13%
2024/10/09196.20196.7096.1001,5850.00%
2024/10/04298.30198.8098.8011,6850.06%
2024/09/3000.001105.00100.00-11,706-0.06%
2024/09/24297.8000.0096.6022,2460.09%
2024/09/2000.000.4102.50101.00-0.42,278-0.02%
2024/09/192104.0000.00102.5022,2880.09%
2024/09/1800.003116.17116.50-32,273-0.13%
2024/09/1300.003105.17105.00-32,328-0.13%
2024/09/123104.001104.00104.0022,3690.08%
2024/09/052107.2500.00105.5022,5660.08%
2024/09/041110.0000.00109.0012,5940.04%
2024/09/031115.0000.00113.5012,6340.04%
2024/08/292118.751120.00118.0012,8210.04%
2024/08/281119.5000.00119.0012,8880.03%
2024/08/274118.752119.00122.0022,9580.07%
2024/08/2600.001.1120.93120.50-1.12,986-0.04%
2024/08/222115.5000.00114.5023,0030.07%
2024/08/212.3115.441116.50117.001.32,9980.04%
2024/08/2000.0010118.45116.00-102,973-0.34%
2024/08/1600.004112.25113.00-42,933-0.14%
2024/08/145112.0000.00112.0052,9560.17%
2024/08/133110.831107.50113.5022,9810.07%
2024/08/0900.0024108.25107.50-242,926-0.82%
2024/08/071108.503.1107.38108.50-2.12,906-0.07%
2024/08/0626101.60399.40103.00232,8900.80%
2024/08/052.1101.321101.0099.501.12,8530.04%
2024/08/022112.7500.00110.5022,8180.07%
2024/08/011119.0000.00117.0012,8020.04%
2024/07/3000.001119.00116.50-12,779-0.04%
2024/07/295119.604113.88113.5012,7480.04%
2024/07/263.1125.4900.00126.003.12,6920.11%
2024/07/231133.0000.00132.0012,6660.04%
2024/07/228140.8712139.71136.00-42,647-0.15%
2024/07/1968.1159.4364150.46145.504.12,5720.16%
2024/07/182156.004158.38161.50-22,302-0.09%
2024/07/111.3142.5400.00140.001.32,1630.06%
2024/07/092.1154.6800.00143.502.12,1300.10%
2024/07/0800.000143.00146.0002,0830.00%
2024/07/0500.002133.50133.00-22,039-0.10%
2024/07/042132.5000.00135.5022,0270.10%
2024/07/034137.384134.75133.0002,0080.00%
2024/07/0221134.3817136.47140.0041,9350.21%
2024/07/011137.004130.25139.50-31,729-0.17%
2024/06/210.196.0013397.0893.70-1331,351-9.84% 大賣/鉅額交易
2024/06/202498.2700.0099.40241,3081.84%
2024/06/19396.54095.5094.2031,2790.23%
2024/06/181698.2100.0096.10161,2421.29%
2024/06/172792.3200.0091.50271,1952.26%
2024/06/14688.4500.0087.7061,1530.52%
2024/06/131586.45285.4085.30131,1251.16%
2024/06/111083.6800.0082.80101,0510.95%
2024/06/07483.50584.6083.00-11,017-0.10%
2024/06/061682.3200.0081.20169691.65%
2024/06/051982.8700.0087.00199072.09%
2024/06/04383.73784.1980.00-4836-0.48%
2024/06/03484.784.185.2585.00-0.1773-0.01%
2024/05/31980.762679.9182.40-17690-2.46%
2024/05/17470.7500.0069.9044540.88%
2024/05/07165.5000.0065.9014020.25%
2024/04/2900.00165.8065.10-1362-0.28%
2024/04/2600.00169.0066.40-1355-0.28%
2024/04/23164.1000.0064.1012880.35%
2024/04/16161.7000.0061.4012810.36%
2024/04/12064.7000.0064.0002760.00%
2024/04/090.166.0000.0065.900.12720.04%
2024/03/07162.0000.0063.0012270.44%
2024/03/01262.2500.0062.0022300.87%
2024/02/27264.0000.0063.0022310.86%
2024/02/2600.00163.6063.70-1228-0.44%
2024/02/2200.00262.1061.80-2222-0.90%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音